The diligence mandate from Guidant: a patent is only as valuable as the product it protects
Simultaneously, it suppresses glucagon secretion from pancreatic alpha cells, further contributing to improved glycemic control
One such option is semaglutide, an FDA-approved medication that has shown significant promise in helping adults achieve and maintain a healthy weight
Importantly, Retatrutide's unique triple receptor agonismtargeting GLP-1, GIP, and glucagon receptorsappears well-tolerated, with adverse events largely consistent with known effects from the broader GLP-1 class, primarily mild gastrointestinal symptoms such as nausea, decreased appetite, and occasional diarrhea, typically resolving within a few weeks of initiation
Feldman says she expects brand-name drugmakers to shift their legal fight to patent infringement as the shortages end
Can be done with weights, resistance bands, or bodyweight exercises